Srivastava Sapna 4
4 · Aura Biosciences, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Srivastava Sapna
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+14,500→ 14,500 totalExercise: $6.93Exp: 2034-06-20→ Common Stock (14,500 underlying) - Award
Common Stock
2024-06-20+10,500→ 10,500 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.
- [F2]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.